{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:22:49Z","timestamp":1790367769861,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>While mammalian target of rapamycin inhibitors have revolutionized the management of angiofibroma in tuberous sclerosis complex (TS), physical modalities such as laser are still indicated for recalcitrant lesions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>The authors performed a systematic review of the efficacy and safety of laser treatment for TS-related facial angiofibroma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>The electronic databases such as MEDLINE, Embase, PubMed, Cochrane Central Register of Controlled Trials, and Web of Science were searched from inception to October 10, 2023, for eligible records.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Forty-seven articles met the inclusion criteria, representing a total of 217 patients with TS-related facial angiofibroma who received laser treatment. Several lasers have been trialed in patients including carbon dioxide (<jats:italic toggle=\"yes\">n<\/jats:italic> = 95, 43.7%), pulsed dye (<jats:italic toggle=\"yes\">n<\/jats:italic> = 21, 9.7%), argon (<jats:italic toggle=\"yes\">n<\/jats:italic> = 16, 7.4%), neodymium-doped: yttrium aluminum garnet (<jats:italic toggle=\"yes\">n<\/jats:italic> = 12, 5.5%), copper vapor (<jats:italic toggle=\"yes\">n<\/jats:italic> = 9, 4.1%), potassium titanyl phosphate (<jats:italic toggle=\"yes\">n<\/jats:italic> = 7, 3.2%), erbium: yttrium aluminum garnet (<jats:italic toggle=\"yes\">n<\/jats:italic> = 2, 0.9%), lasers and various combination therapies (<jats:italic toggle=\"yes\">n<\/jats:italic> = 55, 25.3%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Potassium titanyl phosphate, pulsed dye, and neodymium-dopsed:yttrium aluminum garnet lasers are better suited to manage the vascular components of angiofibroma while ablative lasers such as erbium: yttrium aluminum garnet and carbon dioxide lasers may present better options for lesions with a prominent fibrous component. While several lasers have been trialed with broadly favorable results, the low level of evidence precludes definitive conclusions, and no single laser appears superior.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000004222","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T21:38:28Z","timestamp":1715377108000},"page":"840-846","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["A Systematic Review of Laser Treatment for Angiofibromas in Tuberous Sclerosis"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1547-8715","authenticated-orcid":false,"given":"Yaron","family":"Gu","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia;"},{"name":"Department of Dermatology, Liverpool Hospital, Liverpool, New South Wales, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3541-7135","authenticated-orcid":false,"given":"Matthew J.","family":"Verheyden","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Sutherland Hospital, Caringbah, New South Wales, Australia;"},{"name":"Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5896-8178","authenticated-orcid":false,"given":"Deshan F.","family":"Sebaratnam","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia;"},{"name":"Department of Dermatology, Liverpool Hospital, Liverpool, New South Wales, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5564-8670","authenticated-orcid":false,"given":"Rose C","family":"Liu","sequence":"additional","affiliation":[{"name":"Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s13023-022-02496-2","article-title":"Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database","volume":"17","author":"Boggarapu","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jdv.18693","article-title":"Analysis of current data on the use of topical mTOR inhibitors in the treatment of facial angiofibromas in tuberous sclerosis complex-An update","volume":"37","author":"Balestri","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamadermatol.2018.0464","article-title":"Efficacy and safety of topical rapamycin in patients with facial angiofibromas secondary to tuberous sclerosis complex: the TREATMENT randomized clinical trial","volume":"154","author":"Koenig","year":"2018","journal-title":"JAMA Dermatol"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00000637-198805000-00005","article-title":"Argon laser surgery of skin lesions in tuberous sclerosis","volume":"20","author":"Pasyk","year":"1988","journal-title":"Ann Plast Surg"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1524-4725.1994.tb03709.x","article-title":"CO2, argon, and pulsed dye laser treatment of angiofibromas","volume":"20","author":"Boixeda","year":"1994","journal-title":"J Dermatol Surg Oncol"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/0190-9622(95)91814-0","article-title":"Treatment of adenoma sebaceum with the copper vapor laser","volume":"33","author":"Kaufman","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2230.1998.00371.x","article-title":"Successful treatment of adenoma sebaceum with the potassium titanyl phosphate laser","volume":"23","author":"Finch","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"R8-20250731","first-page":"585","article-title":"Laser treatment of angiofibromas in tuberous sclerosis","volume":"66","author":"Pignatti","year":"2014","journal-title":"Minerva Pediatr"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/lsm.1090","article-title":"Hot\" KTP-laser treatment of facial angiofibromata","volume":"29","author":"Tope","year":"2001","journal-title":"Lasers Surg Med"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/09546639509086851","article-title":"Treatment of multiple angiofibromata with the pulsed dye laser","volume":"6","author":"Mills","year":"1995","journal-title":"J Dermatol Treat"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1078\/1615-1615-00135","article-title":"CO2, Er:YAG and pulsed dye laser treatment of angiofibromas in patients with tuberous sclerosis","volume":"19","author":"Michel","year":"2004","journal-title":"Med Laser Appl"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1468-3083.2004.01013.x","article-title":"An interesting case of unilateral angiofibromas successfully treated with pulsed dye laser","volume":"18","author":"Sharma","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/ijd.12384","article-title":"Nd: YAG laser for \"fractional\" treatment of angiofibromas","volume":"53","author":"Ma","year":"2014","journal-title":"Int J Dermatol"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-2001-13107","article-title":"Tuber\u00f6se Sklerose: Kontrollierte Feinstablation der Angiofibrome im Gesichtsbereich mit einem modifizierten Erbium:YAG-Laser","volume":"27","author":"Weidmann","year":"2001","journal-title":"Akt Dermatol"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/ajd.12034","article-title":"Lasers and laser-like devices: part one","volume":"54","author":"Stewart","year":"2013","journal-title":"Australas J Dermatol"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0733-8635(05)70247-3","article-title":"Use of lasers in pediatric dermatology","volume":"16","author":"Morelli","year":"1998","journal-title":"Dermatol Clin"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajd.12111","article-title":"Lasers and laser-like devices: part two","volume":"55","author":"Sebaratnam","year":"2014","journal-title":"Australas J Dermatol"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1524-4725.1990.tb00041.x","article-title":"Angiofibromas in tuberous sclerosis: comparison of treatment by carbon dioxide and argon laser","volume":"16","author":"Janniger","year":"1990","journal-title":"J Dermatol Surg Oncol"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00266-013-0252-8","article-title":"CO2\/Erbium:YAG\/Dye laser combination: an effective and successful treatment for angiofibromas in tuberous sclerosis","volume":"38","author":"Fioramonti","year":"2014","journal-title":"Aesthet Plast Surg"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1524-4725.2009.01304.x","article-title":"Treatment of angiofibromas of tuberous sclerosis with 5-aminolevulinic acid blue light photodynamic therapy followed by immediate pulsed dye laser","volume":"35","author":"Weinberger","year":"2009","journal-title":"Dermatol Surg"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/DSS.0000000000004047","article-title":"Adjuvant topical sirolimus for pulsed dye laser in pediatric capillary malformation","volume":"50","author":"Gu","year":"2024","journal-title":"Dermatol Surg"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000357033","article-title":"Treatment of angiofibromas in tuberous sclerosis complex: the effect of topical rapamycin and concomitant laser therapy","volume":"228","author":"Park","year":"2014","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000489089","article-title":"Comparative effects of topical 0.2% sirolimus for angiofibromas in adults and pediatric patients with tuberous sclerosis complex","volume":"234","author":"Lee","year":"2018","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/ced.12398","article-title":"Facial Angiofibroma Severity Index (FASI): reliability assessment of a new tool developed to measure severity and responsiveness to therapy in tuberous sclerosis-associated facial angiofibroma","volume":"39","author":"Salido-Vallejo","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"6255339","DOI":"10.1155\/2022\/6255339","article-title":"Mammalian target of rapamycin inhibitors and wound healing complications in kidney transplantation: old myths and new realities","volume":"2022","author":"Mabood Khalil","year":"2022","journal-title":"J Transplant"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"555","DOI":"10.5021\/ad.2019.31.5.555","article-title":"Use of topical rapamycin as maintenance treatment after a single session of fractionated CO2 Laser Ablation: a method to enhance percutaneous drug delivery","volume":"31","author":"Oh","year":"2019","journal-title":"Ann Dermatol"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2133.2002.04968.x","article-title":"Carbon dioxide and pulsed dye laser treatment of angiofibromas in 29 patients with tuberous sclerosis","volume":"147","author":"Papadavid","year":"2002","journal-title":"Br J Dermatol"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0001-7310(05)73121-5","article-title":"Long-term follow up of angiofibromas treated with CO2 laser in 23 patients with tuberous sclerosis","volume":"96","author":"Belmar","year":"2005","journal-title":"Actas Dermosifiliogr"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00266-013-0252-8","article-title":"CO2\/Erbium:YAG\/Dye laser combination: an effective and successful treatment for angiofibromas in tuberous sclerosis","volume":"38","author":"Fioramonti","year":"2014","journal-title":"Aesthetic Plast Surg"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/lsm.20939","article-title":"New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis","volume":"42","author":"Weiss","year":"2010","journal-title":"Lasers Surg Med"},{"key":"R31-20250731","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1468-3083.2011.04212.x","article-title":"Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis - associated facial angiofibroma","volume":"26","author":"Salido","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R32-20250731","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/lsm.22189","article-title":"Targeted topical and combination laser surgery for the treatment of angiofibromas","volume":"45","author":"Bae-Harboe","year":"2013","journal-title":"Lasers Surg Med"},{"key":"R33-20250731","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/jocd.12725","article-title":"Facial angiofibromas treated by rapamycin 0.05% ointment and a combined laser therapy","volume":"17","author":"Negosanti","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"R34-20250731","first-page":"19","article-title":"Treatment of tuberous sclerosis facial angiofibromas with erbium-yttrium aluminium garnet laser and topical sirolimus 0.25%","volume":"54","author":"Botsali","year":"2020","journal-title":"Turkderm-Turk Arch Dermatol Venereol"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/lsm.23443","article-title":"Combination Therapy for the Treatment of Complex Vascular Lesions","volume":"53","author":"Herold","year":"2021","journal-title":"Lasers Surg Med"},{"key":"R36-20250731","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1542\/peds.2015-0025","article-title":"Inhibition of Angiofibromas in a Tuberous Sclerosis Patient Using Topical Timolol 0.5% Gel","volume":"136","author":"Krakowski","year":"2015","journal-title":"Pediatrics"},{"key":"R37-20250731","doi-asserted-by":"crossref","first-page":"102725","DOI":"10.1016\/j.pdpdt.2022.102725","article-title":"The combination of photodynamic therapy and ultrapulse carbon dioxide laser for facial angiofibromas in tuberous sclerosis complex: A case report","volume":"37","author":"Wang","year":"2022","journal-title":"Photodiagnosis Photodyn Ther"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:00:57Z","timestamp":1753999257000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004222","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]}}}